Literature DB >> 25749987

A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.

Junfang Yan1, Chen Jingbo, Deguang Wang, Shengxue Xie, Liang Yuan, Xing Zhong, Li Hao.   

Abstract

OBJECTIVES: The objective of this study was to investigate α-Klotho and fibroblast growth factor receptor 1 (FGFR1) expression in hyperplastic parathyroid glands, as well as their role in the development of renal hyperparathyroidism.
METHODS: Hyperplastic parathyroid glands (n = 90) were obtained from 24 patients who received parathyroidectomy due to secondary renal hyperparathyroidism. Normal parathyroid tissue was obtained from glands (n = 6) that were inadvertently removed, in conjunction with thyroidectomy, from patients with thyroid carcinoma. The expression of α-Klotho and FGFR1 in the parathyroid tissue was detected using immunohistochemical staining.
RESULTS: The expression of α-Klotho and FGFR1 was significantly reduced in the hyperplastic parathyroid tissue compared to that in the normal parathyroid tissue. The expression of α-Klotho decreased further with increasing parathyroid pathology. A significant positive correlation was observed between α-Klotho and FGFR1 (r = 0.38, P < 0.01). FGFR1 (r = -0.21, P < 0.05) and α-Klotho (r = -0.42, P < 0.01) were negatively correlated with the volume of the hyperplastic parathyroid tissue.
CONCLUSION: The expression of α-Klotho and FGFR1 decreases in the parathyroid glands of dialysis patients with secondary hyperparathyroidism, and this decrease may play an important role in the pathogenesis of secondary renal hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25749987     DOI: 10.1007/s11255-015-0917-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  21 in total

1.  Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?

Authors:  Tilman B Drüeke
Journal:  Kidney Int       Date:  2010-12       Impact factor: 10.612

2.  Severe uremic leontiasis ossea ameliorated by total parathyroidectomy.

Authors:  Ling Zhang; Li Yao; Wei-Jing Bian; Hong-Liang Rui
Journal:  Kidney Int       Date:  2009-11       Impact factor: 10.612

Review 3.  Klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

Review 4.  Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease.

Authors:  M Fukagawa; S Nakanishi; J J Kazama
Journal:  Kidney Int Suppl       Date:  2006-07       Impact factor: 10.545

5.  Mutation of the mouse klotho gene leads to a syndrome resembling ageing.

Authors:  M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

6.  Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

Authors:  Shohei Nakanishi; Junichiro James Kazama; Tomoko Nii-Kono; Kentaro Omori; Takeyoshi Yamashita; Seiji Fukumoto; Fumitake Gejyo; Takashi Shigematsu; Masafumi Fukagawa
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

7.  Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.

Authors:  H Galitzer; I Z Ben-Dov; Justin Silver; Tally Naveh-Many
Journal:  Kidney Int       Date:  2009-12-16       Impact factor: 10.612

8.  Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

Authors:  Takashi Shigematsu; Junichiro James Kazama; Takeyoshi Yamashita; Seiji Fukumoto; Tatsuo Hosoya; Fumitake Gejyo; Masafumi Fukagawa
Journal:  Am J Kidney Dis       Date:  2004-08       Impact factor: 8.860

9.  alpha-Klotho as a regulator of calcium homeostasis.

Authors:  Akihiro Imura; Yoshihito Tsuji; Miyahiko Murata; Ryota Maeda; Koji Kubota; Akiko Iwano; Chikashi Obuse; Kazuya Togashi; Makoto Tominaga; Naoko Kita; Ken-ichi Tomiyama; Junko Iijima; Yoko Nabeshima; Makio Fujioka; Ryo Asato; Shinzo Tanaka; Ken Kojima; Juichi Ito; Kazuhiko Nozaki; Nobuo Hashimoto; Tetsufumi Ito; Takeshi Nishio; Takashi Uchiyama; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal:  Science       Date:  2007-06-15       Impact factor: 47.728

10.  Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.

Authors:  Chiaki Kumata; Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Ai Nakazawa; Fumiko Kondo; Yoshiyuki Kadokura; Eriko Kinugasa; Tadao Akizawa
Journal:  Am J Nephrol       Date:  2010-01-06       Impact factor: 3.754

View more
  6 in total

1.  Differential Expression of FGFRs Signaling Pathway Components in Bladder Cancer: A Step Toward Personalized Medicine.

Authors:  Ousati Ashtiani Z; Tavakkoly-Bazzaz J; Salami Sa; Pourmand Mr; Mansouri F; Mashahdi R; Pourmand G
Journal:  Balkan J Med Genet       Date:  2017-12-29       Impact factor: 0.519

2.  Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort.

Authors:  Guillaume Jean; Marie Hélène Lafage-Proust; Jean Claude Souberbielle; Sylvain Lechevallier; Patrik Deleaval; Christie Lorriaux; Jean Marc Hurot; Brice Mayor; Manolie Mehdi; Charles Chazot
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

Review 3.  The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD.

Authors:  Chien-Lin Lu; Dong-Feng Yeih; Yi-Chou Hou; Guey-Mei Jow; Zong-Yu Li; Wen-Chih Liu; Cai-Mei Zheng; Yuh-Feng Lin; Jia-Fwu Shyu; Remy Chen; Chung-Yu Huang; Kuo-Cheng Lu
Journal:  Nutrients       Date:  2018-12-03       Impact factor: 5.717

4.  The prognostic value of soluble Klotho in patients with haemodialysis: a systematic review and meta-analysis.

Authors:  Qi-Feng Liu; Sha-Sha Li; Li-Xia Yu; Jian-Hua Feng; Li-Li Xue; Guo-Yuan Lu
Journal:  Ther Adv Chronic Dis       Date:  2020-07-30       Impact factor: 5.091

Review 5.  The controversy of klotho as a potential biomarker in chronic kidney disease.

Authors:  Li-Xia Yu; Sha-Sha Li; Min-Yue Sha; Jia-Wei Kong; Jian-Ming Ye; Qi-Feng Liu
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

6.  Analysis of the kinetics of the parathyroid hormone, and of associated patient outcomes, in a cohort of haemodialysis patients.

Authors:  Guillaume Jean; Jean-Claude Souberbielle; Eric Zaoui; Christie Lorriaux; Jean-Marc Hurot; Brice Mayor; Patrik Deleaval; Manolie Mehdi; Charles Chazot
Journal:  BMC Nephrol       Date:  2016-10-18       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.